Le Lézard
Classified in: Health, Business
Subjects: SVY, ECO, EGV

2022 Marked a Record for German R&D Investments


BERLIN, March 19, 2024 /PRNewswire/ -- EUR 121.4 billion was spent in Germany on research and development ? more than ever before in a single year.

According to the Federal Statistical Office, the amount of money devoted to R&D rose by seven percent in 2022, reaching an all-time high. The figures include commercial, university and non-university research.

R&D investments by businesses grew by eight percent, reaching EUR 81.8 billion. That's more than two-thirds of all the money invested in R&D.

Expenditures for research and development in Germany have amounted to 3.1 percent of GDP since 2020. Germany has exceeded the EU guideline of three percent for R&D investments for the past six years in a row.

"The German government intends to increase the percentage of R&D to GDP to 3.5 percent by 2025," says Robert Hermann, CEO of the German agency for international economic promotion, Germany Trade & Invest. "The growth in this investment shows how much Germany prioritized research and development. It's a central element in Germany's drive to be one of the leading locations for investments in high tech."

Germany Trade & Invest (GTAI) is the economic promotion agency of the Federal Republic of Germany. GTAI supports German companies setting up in foreign markets, promotes Germany as a business location and assists foreign companies setting up shop in Germany.

Contact:

Andreas Bilfinger 

Germany Trade & Invest

T: +49 30200099173

[email protected] 

SOURCE Germany Trade & Invest


These press releases may also interest you

at 15:25
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

at 11:55
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

at 09:00
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...

at 07:56
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy. The focus of the collaboration is to...

at 06:00
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that OC Fertility® + OC Biogenix® located in Newport Beach, Orange County, California will join SOE's expert panel to provide second opinions for fertility...

at 05:00
Scientology Network's VOICES FOR HUMANITY, the weekly series presenting heroic change makers from a variety of faiths, cultures and nations, working to uplift their communities, announces a new episode featuring anti-drug activist Robert Galibert....



News published on and distributed by: